These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12781343)

  • 1. Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes.
    Goto D; Fujii S; Kaneko T; Furumoto T; Sugawara T; Tarikuz Zaman AK; Imagawa S; Dong J; Nakai Y; Mishima T; Sobel BE; Kitabatake A
    Biochem Pharmacol; 2003 Jun; 65(11):1907-14. PubMed ID: 12781343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
    Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
    Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
    J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression.
    Takeda K; Ichiki T; Tokunou T; Iino N; Fujii S; Kitabatake A; Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):868-73. PubMed ID: 11348889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease.
    Lundgren CH; Brown SL; Nordt TK; Sobel BE; Fujii S
    Circulation; 1996 Jan; 93(1):106-10. PubMed ID: 8616916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
    Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
    Edlund S; Landström M; Heldin CH; Aspenström P
    Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes.
    Pandey M; Loskutoff DJ; Samad F
    FASEB J; 2005 Aug; 19(10):1317-9. PubMed ID: 15928193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.
    Nagatoya K; Moriyama T; Kawada N; Takeji M; Oseto S; Murozono T; Ando A; Imai E; Hori M
    Kidney Int; 2002 May; 61(5):1684-95. PubMed ID: 11967018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
    Samarakoon R; Higgins PJ
    J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
    Kralisch S; Klein J; Lossner U; Blüher M; Paschke R; Stumvoll M; Fasshauer M
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):56-62. PubMed ID: 16713670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.
    Rikitake Y; Liao JK
    Circulation; 2005 Jun; 111(24):3261-8. PubMed ID: 15956119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
    Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
    Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
    Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
    Samad F; Yamamoto K; Pandey M; Loskutoff DJ
    Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
    Samad F; Loskutoff DJ
    Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.
    Rees RW; Foxwell NA; Ralph DJ; Kell PD; Moncada S; Cellek S
    J Urol; 2003 Dec; 170(6 Pt 1):2517-22. PubMed ID: 14634463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
    Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes.
    Chen B; Lam KS; Wang Y; Wu D; Lam MC; Shen J; Wong L; Hoo RL; Zhang J; Xu A
    Biochem Biophys Res Commun; 2006 Mar; 341(2):549-56. PubMed ID: 16427606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.